Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+2.43M
-
Total reported value, excl. options
-
$526M
-
Value change
-
+$70.7M
-
Put/Call ratio
-
3.37
-
Number of buys
-
65
-
Number of sells
-
-21
-
Price
-
$18.46
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q4 2017
112 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q4 2017.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 31.6M outstanding shares and own 90.13% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.29M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.21M shares), BlackRock Inc. (1.97M shares), FRAZIER MANAGEMENT LLC (1.89M shares), Rock Springs Capital Management LP (1.89M shares), MACQUARIE GROUP LTD (1.62M shares), FRANKLIN RESOURCES INC (1.51M shares), Sectoral Asset Management Inc (1.43M shares), TPG Group Holdings (SBS) Advisors, Inc. (1.39M shares), and Vanguard Group Inc (1.04M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.